BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
6.81
+1.06 (18.43%)
Mar 6, 2026, 4:00 PM EST - Market closed
BiomX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Selling, General & Admin | 11.74 | 14.79 | 9.56 | 10.56 | 12.28 | Upgrade
|
| Research & Development | 19.18 | 20.76 | 15.79 | 15.14 | 21.67 | Upgrade
|
| Amortization of Goodwill & Intangibles | - | - | - | 1.52 | 1.52 | Upgrade
|
| Operating Expenses | 30.92 | 35.55 | 25.35 | 27.22 | 35.46 | Upgrade
|
| Operating Income | -30.92 | -35.55 | -25.35 | -27.22 | -35.46 | Upgrade
|
| Interest Expense | -0.02 | -0.87 | -2.4 | -2.07 | -0.7 | Upgrade
|
| Interest & Investment Income | 0.46 | 1.05 | 1.12 | 0.46 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.22 | -0.05 | 0.18 | 0.45 | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.05 | 26.69 | 0.3 | 0.12 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -25.65 | -8.74 | -26.15 | -28.25 | -36.16 | Upgrade
|
| Merger & Restructuring Charges | - | -0.89 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | -0.8 | - | - | - | Upgrade
|
| Asset Writedown | -1.65 | -4.05 | - | - | - | Upgrade
|
| Other Unusual Items | 2.95 | - | - | - | - | Upgrade
|
| Pretax Income | -36.19 | -17.71 | -26.15 | -28.25 | -36.16 | Upgrade
|
| Income Tax Expense | 0.01 | 0.01 | 0.02 | 0.07 | 0.07 | Upgrade
|
| Net Income | -36.2 | -17.73 | -26.17 | -28.32 | -36.23 | Upgrade
|
| Net Income to Common | -36.2 | -17.73 | -26.17 | -28.32 | -36.23 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 115.25% | 180.48% | 71.94% | 14.79% | 12.77% | Upgrade
|
| EPS (Basic) | -22.19 | -25.37 | -96.86 | -180.22 | -264.65 | Upgrade
|
| EPS (Diluted) | -22.19 | -58.31 | -96.90 | -180.22 | -264.65 | Upgrade
|
| Free Cash Flow | -26.39 | -37.01 | -21.34 | -29.2 | -31.26 | Upgrade
|
| Free Cash Flow Per Share | -16.18 | -48.84 | -78.97 | -185.86 | -228.33 | Upgrade
|
| EBITDA | -28 | -33.75 | -24.48 | -26.22 | -34.42 | Upgrade
|
| D&A For EBITDA | 2.92 | 1.8 | 0.87 | 1 | 1.05 | Upgrade
|
| EBIT | -30.92 | -35.55 | -25.35 | -27.22 | -35.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.